Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age
Table 1
Clinical and demographic characteristics of eyes affected by central and branch retinal vein occlusion in patients aged under 50 years of age.
All patients ()
Central RVO ()
Branch RVO ()
Age (range)
(18-49)
(18-48)
(28-49)
Sex (%)
Male
27 (71%)
17 (68%)
10 (77%)
Female
11 (29%)
8 (32%)
3 (23%)
Baseline BCVA† (range)
LogMAR‡ (0.1-0.7)
LogMAR (0.1-0.6)
(Snellen equivalents)
(20/50)
(20/50)
Follow-up BCVA (range)
LogMAR (0-0.3)
LogMAR (0-0.5)
(Snellen equivalents)
(20/25)
(20/30)
Baseline CFT§ (range)
μm (305-940)
μm (308-580)
Follow-up CFT (range)
μm (230-540)
μm (221-357)
Injections (range)
RVO: retinal vein occlusion. †BCVA: best-corrected visual acuity. ‡LogMAR: logarithm of the minimal angle of resolution. §CFT: central foveal thickness.
